palbociclib
Showing 1 - 25 of 156
Breast Cancer, Head Neck Cancer Trial in Seoul (Palbociclib, Cetuximab, Fulvestrant)
Not yet recruiting
- Breast Cancer
- Head and Neck Cancer
- Palbociclib
- +3 more
-
Seoul, Seoul-teukbyeolsi [seoul], Korea, Republic ofSamsung Medical Center
Jun 28, 2022
Advanced Dedifferentiated Liposarcoma, Locally Advanced Dedifferentiated Liposarcoma, Metastatic Dedifferentiated Liposarcoma
Not yet recruiting
- Advanced Dedifferentiated Liposarcoma
- +5 more
- Palbociclib
- +5 more
- (no location specified)
Jan 11, 2023
DCIS Trial in Washington (Palbociclib)
Recruiting
- DCIS
- Palbociclib
-
Washington, District of ColumbiaMedStar Georgetown University Hospital
Apr 5, 2022
Advanced Clear Cell Renal Cell Carcinoma Trial in Boston (Axitinib, Palbociclib, Avelumab)
Not yet recruiting
- Advanced Clear Cell Renal Cell Carcinoma
- Axitinib
- +2 more
-
Boston, Massachusetts
- +2 more
Jun 27, 2022
Head and Neck Squamous Cell Carcinoma Trial in Saint Louis (drug, radiation, procedure)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Palbociclib
- +5 more
-
Saint Louis, MissouriWashington University School of Medicine
Feb 25, 2022
Patterns and Clinical Outcomes of Palbociclib Treated Israel
Completed
- Metastatic Breast Cancer
- palbociclib
-
Herzliya Pituach, IsraelPfizer Pharmaceuticals Israel Ltd.
Jan 20, 2022
COVID-19 Trial in Brandenburg an der Havel (Palbociclib)
Active, not recruiting
- COVID-19
- Palbociclib
-
Brandenburg an der Havel, GermanyUniversitätsklinikum Brandenburg an der Havel
May 11, 2022
Renal Cell Carcinoma Trial in Macquarie University, Haifa (Belzutifan, Palbociclib)
Recruiting
- Renal Cell Carcinoma
- Belzutifan
- Palbociclib
-
Macquarie University, New South Wales, Australia
- +1 more
Aug 15, 2022
Breast Tumor Female Trial in Melbourne (Venetoclax, Palbociclib, Letrozole)
Recruiting
- Breast Neoplasm Female
- Venetoclax
- +2 more
-
Melbourne, Victoria, Australia
- +2 more
Mar 10, 2022
Breast Cancer Stage IV, Unresectable Locally Advanced Invasive Breast Cancer, Metastatic Invasive Breast Cancer Trial in Boston
Completed
- Breast Cancer Stage IV
- +2 more
- Palbociclib
- Bazedoxifene
-
Boston, Massachusetts
- +1 more
Jun 27, 2022
Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,
Recruiting
- Breast Cancer
- +2 more
- Palbociclib
- +3 more
-
Taipei City, Taiwan
- +1 more
Mar 15, 2023
Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant)
Recruiting
- Metastatic Breast Cancer
- Palbociclib
- Fulvestrant
-
Washington, District of Columbia
- +4 more
Jan 10, 2022
Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)
Active, not recruiting
- Metastatic Breast Cancer
- Fulvestrant
- +2 more
-
Pittsburgh, PennsylvaniaMagee-Womens Hospital UPMC
Jul 22, 2021
Head and Neck Squamous Cell Carcinoma Trial in La Jolla (Avelumab, Palbociclib, Cetuximab)
Active, not recruiting
- Head and Neck Squamous Cell Carcinoma
- Avelumab
- +2 more
-
La Jolla, CaliforniaUC San Diego Moores Cancer Center
Feb 16, 2022
Real-World Evidence In Patients Treated With Palbociclib
Recruiting
- Metastatic Breast Cancer
- Palbociclib
-
Timisoara, Timiș, RomaniaAsociatia Oncohelp - Centrul de Oncologie Oncohelp
Feb 15, 2022
Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)
Active, not recruiting
- Ewing Sarcoma
- Ewing's Sarcoma Recurrent
- Palbociclib
- Ganitumab
-
Boston, Massachusetts
- +2 more
Mar 21, 2022
Cancer of the Colon, Colon Cancer, Colon Tumors Trial in Chapel Hill (Cetuximab, Palbociclib)
Recruiting
- Cancer of the Colon
- +4 more
- Cetuximab
- Palbociclib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Jan 25, 2022
Colorectal Carcinoma, Lung Adenocarcinoma, Malignant Solid Tumor Trial in Buffalo (Binimetinib, Palbociclib, Therapeutic
Recruiting
- Colorectal Carcinoma
- +3 more
- Binimetinib
- +2 more
-
Buffalo, New YorkRoswell Park Cancer Institute
May 11, 2022
Tumor, Solid, Pancreatic Cancer Trial in Chapel Hill (Ulixertinib, Palbociclib)
Active, not recruiting
- Tumor, Solid
- Pancreatic Cancer
- Ulixertinib
- Palbociclib
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center
Jan 6, 2022
Breast Cancer, Breast Carcinoma, Cancer of Breast Trial in Saint Louis, Lincoln (Palbociclib, Letrozole, Fulvestrant)
Active, not recruiting
- Breast Cancer
- +3 more
- Palbociclib
- +7 more
-
Saint Louis, Missouri
- +1 more
Jul 20, 2022
Estrogen Receptor Positive, HER2/Neu Negative, Invasive Breast Carcinoma Trial in Los Angeles (procedure, drug, other)
Terminated
- Estrogen Receptor Positive
- +16 more
- Biopsy of Breast
- +5 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Apr 4, 2022
Metastatic Malignant Tumor to Brain Trial in Boston (Palbociclib)
Recruiting
- Metastatic Malignant Neoplasm to Brain
- Palbociclib
-
Boston, Massachusetts
- +1 more
Oct 25, 2021
Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)
Recruiting
- Estrogen Receptor-positive Breast Cancer
- HER2-positive Breast Cancer
- Palbociclib
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Hospital
Sep 29, 2021